KRAS and pancreatic adenocarcinoma: As expected, human PanNETs and MAP model tumors exhibit distinct transcriptional programs from those found in the KRAS-driven pancreatic adenocarcinoma KPC model, including those associated with inflammatory response, allograft rejection, NFkB, STAT3, and KRAS pathways.